A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.

Autor: Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Plieskatt JL; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Soulama BI; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Bougouma EC; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Naghizadeh M; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Barry A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Yaro JBB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ezinmegnon S; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Henry N; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ofori EA; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Adu B; Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana., Singh SK; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Konkobo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Lövgren Bengtsson K; Novavax AB, Uppsala, Sweden., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Carnrot C; Novavax AB, Uppsala, Sweden., Reimer JM; Novavax AB, Uppsala, Sweden., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Tienta M; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Ouedraogo IN; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Sagara I; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Theisen M; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Apr 01; Vol. 134 (7). Date of Electronic Publication: 2024 Apr 01.

A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.

Autor: Keitel WA; Departments of Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, TX, United States. Electronic address: wkeitel@bcm.edu., Potter GE; The Emmes Corporation, United States., Diemert D; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC, United States., Bethony J; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC, United States., El Sahly HM; Departments of Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, TX, United States., Kennedy JK; The Emmes Corporation, United States., Patel SM; Departments of Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, TX, United States., Plieskatt JL; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC, United States., Jones W; Division of Microbiology and Infectious Diseases (DMID), National Institutes of Allergy and Infectious. Diseases (NIAID), National Institutes of Health (NIH), United States., Deye G; Division of Microbiology and Infectious Diseases (DMID), National Institutes of Allergy and Infectious. Diseases (NIAID), National Institutes of Health (NIH), United States., Bottazzi ME; Departments of Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, TX, United States; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States., Hotez PJ; Departments of Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, TX, United States; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States., Atmar RL; Departments of Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, TX, United States.

Publikováno v: Vaccine [Vaccine] 2019 Oct 08; Vol. 37 (43), pp. 6500-6509. Date of Electronic Publication: 2019 Sep 09.

Peptide data on the disulfide bond analysis of baculovirus produced Pfs25 by LC-MSMS.

Autor: Lee SM; PATH Malaria Vaccine Initiative (MVI), 455 Massachusetts Avenue NW, Suite 1000, Washington, DC 20001-2621, USA., Plieskatt JL; PATH Malaria Vaccine Initiative (MVI), 455 Massachusetts Avenue NW, Suite 1000, Washington, DC 20001-2621, USA., King CR; PATH Malaria Vaccine Initiative (MVI), 455 Massachusetts Avenue NW, Suite 1000, Washington, DC 20001-2621, USA.

Publikováno v: Data in brief [Data Brief] 2018 Mar 12; Vol. 18, pp. 209-233. Date of Electronic Publication: 2018 Mar 12 (Print Publication: 2018).

Fit for genomic and proteomic purposes: Sampling the fitness of nucleic acid and protein derivatives from formalin fixed paraffin embedded tissue.

Autor: Yakovleva A; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington DC, United States of America., Plieskatt JL; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington DC, United States of America.; AIDS and Cancer Specimen Resource (ACSR), The George Washington University, Washington DC, United States of America., Jensen S; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington DC, United States of America., Humeida R; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington DC, United States of America.; AIDS and Cancer Specimen Resource (ACSR), The George Washington University, Washington DC, United States of America., Lang J; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington DC, United States of America.; AIDS and Cancer Specimen Resource (ACSR), The George Washington University, Washington DC, United States of America., Li G; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington DC, United States of America., Bracci P; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America.; AIDS and Cancer Specimen Resource (ACSR), University of California at San Francisco, San Francisco, CA, United States of America., Silver S; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington DC, United States of America.; AIDS and Cancer Specimen Resource (ACSR), The George Washington University, Washington DC, United States of America., Bethony JM; Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington DC, United States of America.; AIDS and Cancer Specimen Resource (ACSR), The George Washington University, Washington DC, United States of America.

Publikováno v: PloS one [PLoS One] 2017 Jul 25; Vol. 12 (7), pp. e0181756. Date of Electronic Publication: 2017 Jul 25 (Print Publication: 2017).

Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini.

Autor: Plieskatt JL; Department of Microbiology, Immunology & Tropical Medicine, School of Medicine & Health Sciences, The George Washington University, Washington, DC 20037, USA; Research Center for the Neglected Diseases of Poverty, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA., Rinaldi G; Department of Microbiology, Immunology & Tropical Medicine, School of Medicine & Health Sciences, The George Washington University, Washington, DC 20037, USA; Research Center for the Neglected Diseases of Poverty, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA; Departamento de Genética, Facultad de Medicina, Universidad de la República (UDELAR), Montevideo 11800, Uruguay., Feng Y; Department of Microbiology, Immunology & Tropical Medicine, School of Medicine & Health Sciences, The George Washington University, Washington, DC 20037, USA; Research Center for the Neglected Diseases of Poverty, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA., Peng J; Department of Microbiology, Immunology & Tropical Medicine, School of Medicine & Health Sciences, The George Washington University, Washington, DC 20037, USA; Research Center for the Neglected Diseases of Poverty, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA., Yonglitthipagon P; Infectious Disease and Cancer, Queensland Institute for Medical Research, Brisbane, Australia., Easley S; Department of Pathology, School of Medicine and Health Sciences, George Washington University, Washington, DC, USA., Laha T; Department of Parasitology, Khon Kaen University School of Medicine, Khon Kaen 40002, Thailand., Pairojkul C; Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand., Bhudhisawasdi V; Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand., Sripa B; Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand., Brindley PJ; Department of Microbiology, Immunology & Tropical Medicine, School of Medicine & Health Sciences, The George Washington University, Washington, DC 20037, USA; Research Center for the Neglected Diseases of Poverty, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA., Mulvenna JP; Infectious Disease and Cancer, Queensland Institute for Medical Research, Brisbane, Australia; School of Biomedical Sciences, Faculty of Medicine and Biomedical Sciences, University of Queensland, Brisbane, Australia., Bethony JM; Department of Microbiology, Immunology & Tropical Medicine, School of Medicine & Health Sciences, The George Washington University, Washington, DC 20037, USA; Research Center for the Neglected Diseases of Poverty, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA. Electronic address: jbethony@gwu.edu.

Publikováno v: Journal of hepatology [J Hepatol] 2014 Oct; Vol. 61 (4), pp. 850-8. Date of Electronic Publication: 2014 Jun 03.